Vimian Group AB (VIMIAN) fair value: what the stock is really worth
As of Oct 16, 2026: fair value (intrinsic value) of Vimian Group AB stock SEK 39.22, price SEK 38.25, upside +2.5%, quality 59 out of 100. Rating: fairly valued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 2, 2026.
How to read this chart
60‑month range kr 20.08 – kr 117.16 · fair‑value band kr 24.65 – kr 50.98 · the kr 38.25 price screens below the kr 39.22 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 2, 2026.
Follow Vimian Group in your weekly email
Every Wednesday you see whether Vimian Group is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through four segments: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services.
Show moreShow less
The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name.
It also provides procurement and tech-driven operations, such as online marketing, education, and HR, as well as a community for veterinary clinics through a membership-based platform under the VetFamily brand name; and surgical and dental products to veterinary clinics and universities, including dentistry and companion animal orthopedics under the Movora brand name.
Vimian Group AB (publ) was incorporated in 2020 and is headquartered in Stockholm, Sweden.
Stock analysis
Vimian Group AB (VIMIAN) currently trades at kr 38.25, while our model-based Fair Value estimate is kr 39.22, so the stock looks roughly fairly valued today (gap 2.5%).
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of kr 38.76 per share, and 6 of the 22 models we run sit above the kr 38.25 price.
Bear case: the Economic Profit group reads lowest at kr 7.44, and 16 of the 22 models stay below the price. Data coverage for this calculation is medium.
Scenario range: kr 24.65 (bear) to kr 50.98 (bull), the price of kr 38.25 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 59/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Vimian Group AB reported revenue of €425M in FY2025 versus €173M in FY2021, a compound +25.1%/yr. Reported net income was €31.3M in FY2025, compounding +47.6%/yr from FY2021.
Key figures
Market cap 20.2B SEK (≈ $2.0B) Mid · P/E ratio 48.3 · P/S ratio 3.56 · EPS (TTM) kr 0.7900 · Net margin 7.4% · Return on equity 5.3% · Return on assets (EBIT) 4.6% · Operating margin 18.4%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 47 out of 100 (low confidence).
What moves the price
Analysts expect earnings well below the last reported figure (earnings in transition, for example expiring patents or contracts); a fair value that looks fair on trailing earnings may then be too optimistic.
The share trades at its 52-week high and 53% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −5% fair-value upside, at 3%, VIMIAN screens cheaper than that median.
Fair Value models
Bearkr 24.65Fair Value kr 39.22Bullkr 50.98
Price kr 38.25 · Upside +2.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (kr 0.6320 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.90/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+13.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+25.3%
Start year 2020 (pandemic)
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+76.1%
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.
+15.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year+15.8%
Dividend (yield on the price)0.0%
Profit margin 2019 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.5% → 17%
2025 sits 104% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Growth Forecast
A lot of optimism in the price
The price assumes less growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+15.7%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+9.2%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in EUR, euro area: IMF forecast 2.2% a year to 2030, 2.6% from 2016 to 2025) that is about +13.2% a year for the price and +6.9% for the forecasts.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Diagnostics & Research · 124 stocks
Beats the industry median on 8/12 measures
Overall it ranks above its industry peers.
Valuation
Quality Score59 · Above median
Fair Value upside+2.5% · Above median
Profitability
Return on equity (12 months)5.3% · Above median
Return on assets2.8% · Above median
Net margin (12 months)8.2% · Above median
Operating margin (12 months)18.4% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)16.6% · Top 25%
Balance sheet
Debt / equity0.32× · Above median
Valuation Multiplesvs Diagnostics & Research median · lower = cheaper
P/E (12 months)48.3× · Pricier than median
P/B2.60× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Vimian Group AB Fair Value". https://www.fairvalue-calculator.com/stock/VIMIAN
Frequently asked questions
Is Vimian Group AB (VIMIAN) overvalued or undervalued?
As of Oct 2, 2026, our model estimates a fair value of kr 39.22 versus a price of kr 38.25, about +3% upside (fairly valued).
What is the fair value of VIMIAN?
Our model-based fair value for Vimian Group AB is kr 39.22 (as of Oct 2, 2026), built from audited fundamentals. The current price: kr 38.25.
What is the quality score of VIMIAN?
Vimian Group AB has a Quality Score of 59/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Vimian Group AB (VIMIAN)?
Our model-based price target is the fair value of kr 39.22 (as of Oct 2, 2026) from 22 valuation models. Cautious scenario kr 24.65, optimistic scenario kr 50.98. It is a calculation from audited fundamentals, not an analyst target.
What is the Vimian Group AB stock forecast for 2026?
Our models put fair value at kr 39.22, about +3% upside versus a price of kr 38.25 (fairly valued). Cautious scenario kr 24.65, optimistic scenario kr 50.98. The calculation is refreshed regularly with new filings.
What is the revenue of Vimian Group AB (VIMIAN)?
Vimian Group AB reported trailing-twelve-month revenue of about €451M (latest available figure, as of Oct 2, 2026).
What growth is priced into Vimian Group AB (VIMIAN)?
For today's price to be fair in a discounted-cash-flow model, Vimian Group AB would have to grow free cash flow by +15.7 % per year for five years (discount rate 11.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +25.3 % per year. As of Oct 2, 2026.
What discount rate (WACC) does the fair value of VIMIAN use?
Our models discount Vimian Group AB at 11.5 %: a base by market capitalisation (small), damped by beta 1.19, country premium for Sweden. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Vimian Group AB that is +15.7 % per year a year over ten years, using the same discount rate (11.5 %) and the same formula as our fair value.
How much growth has Vimian Group AB (VIMIAN) delivered so far?
Over the past 5 years revenue at Vimian Group AB grew +25.3 % a year. The price currently implies +15.7 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Vimian Group AB (VIMIAN) growing?
The median revenue growth in the sector is +5.6 % a year. That is the yardstick for the growth priced into Vimian Group AB (+15.7 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Vimian Group AB (VIMIAN)?
The free-cash-flow yield on the price is 5.00 %: that much free cash flow Vimian Group AB produces per unit of market value. When it exceeds the discount rate of our models (11.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Vimian Group AB (VIMIAN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Vimian Group AB it is kr 39.22 per share (as of Oct 2, 2026), against a price of kr 38.25. It is the blended result of 22 valuation models (cash flow, earnings, asset, dividend).
Is Vimian Group AB stock overvalued or undervalued in 2026?
As of Oct 2, 2026, VIMIAN trades below its calculated fair value: price kr 38.25, fair value kr 39.22, a gap of about +3% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of VIMIAN?
No. The price is what the market pays today (kr 38.25); the fair value is what the company's own numbers justify (kr 39.22). For Vimian Group AB the two are kr 0.9650 per share apart. That gap is exactly why we show both numbers side by side.
How much is Vimian Group AB worth?
The market values Vimian Group AB at about 20.2B SEK (market capitalisation, as of Oct 2, 2026). Per share that is kr 38.25; our models calculate a fair value of kr 39.22 per share.
What do the bullish and bearish scenarios say about VIMIAN?
Our models span a range for Vimian Group AB: cautious scenario kr 24.65, base kr 39.22, optimistic kr 50.98 per share (as of Oct 2, 2026, price kr 38.25). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of VIMIAN?
Vimian Group AB trades at a price-to-earnings ratio of 48.3 (as of Oct 2, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of kr 39.22 is built from several models across several years. Other multiples: P/B 2.6, P/S 4.0, EV/EBITDA 17.4.
How solid is the balance sheet of Vimian Group AB (VIMIAN)?
Balance-sheet figures for Vimian Group AB (as of Oct 2, 2026): return on equity 5.3%, debt of 0.32 per unit of equity. They feed the Quality Score of 59/100, which measures business quality independently of the share price.
How far is VIMIAN from its 52-week high?
Vimian Group AB trades at kr 38.25, at its 52-week high of kr 38.25 and 53% above the low of kr 24.92 (as of Oct 16, 2026). Distance from the high says nothing about value: that is what the fair value of kr 39.22 is for.
Which stocks are comparable to Vimian Group AB?
From the same area (Healthcare) we also value Thermo Fisher Scientific Inc, Danaher Corporation, WuXi AppTec Co, Agilent Technologies, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Vimian Group AB stock attractive at the current price?
The data as of Oct 2, 2026: price kr 38.25, calculated fair value kr 39.22 (+3%), Quality Score 59/100, from 22 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of VIMIAN calculated?
We run Vimian Group AB through 22 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of kr 39.22, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.8 % above its aggregate fair value. Vimian Group AB currently trades 2 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Vimian Group AB (VIMIAN)?
The closing price on Oct 16, 2026 was kr 38.25. Our model-based fair value is kr 39.22, about +3% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Vimian Group AB right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. A fairly wide model range (kr 24.65 to kr 50.98) leaves room in how you read the outcome.
Key figures of Vimian Group AB
How large is the market capitalisation of Vimian Group AB (VIMIAN)?
The market capitalisation of Vimian Group AB is 20.2B SEK (≈ $2.0B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Vimian Group AB (VIMIAN)?
The price-to-sales ratio of Vimian Group AB is 3.56 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Vimian Group AB (VIMIAN)?
Earnings per share at Vimian Group AB are kr 0.7900 (price ÷ EPS = P/E 48.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Vimian Group AB (VIMIAN)?
The net margin of Vimian Group AB is 7.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Vimian Group AB (VIMIAN)?
The return on equity (ROE) of Vimian Group AB is 5.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Vimian Group AB (VIMIAN)?
On an EBIT basis the return on assets of Vimian Group AB is 4.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Vimian Group AB (VIMIAN)?
The operating margin of Vimian Group AB is 18.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Vimian Group AB (VIMIAN)?
Revenue at Vimian Group AB is growing +16.6% versus a year earlier (3y avg +14.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Vimian Group AB (VIMIAN)?
Earnings per share at Vimian Group AB are growing +0.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Vimian Group AB (VIMIAN) carry?
The net debt of Vimian Group AB is €184M (fiscal year 2025, ≈ 2.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Vimian Group AB in the live analysis
One click puts Vimian Group AB on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Some data
Oct 2, 2026